期刊文献+

血液冷沉淀制备工艺优化方法的研究 被引量:1

下载PDF
导出
摘要 冷沉淀制剂富含凝血因子Ⅷ(FⅧ)和因子Ⅶ(FⅦ)等所有有效成分,具有良好的止血效果。由于冷沉淀中凝血因子半衰期短,对温度要求要求高,必须严格控制生产工艺每一环节。本通过研究对传统工艺不断的改进,摸索出了一套行之有效的冷沉淀制备的质量控制方法。
作者 阎兵
出处 《求医问药(下半月刊)》 2012年第4期332-332,共1页 Seek Medical and Ask The Medicine
  • 相关文献

同被引文献27

  • 1Woodhams B, Girardot O, Blanco M J, et al. Stability of coagula- tion proteins in frozen plasma [ J ]. Blood Coagul Fibrinolysis, 2001,12 (4) :229-236.
  • 2Franchini M, Mannueei PM. Past, present and future of hemo- philia: a narrative review [ J]. Orphanet J Rare Dis, 2012,7:24.
  • 3Mannueci PM. Back to the future : a recent history of haemophilia treatment [ J ]. Haemophilia ,2008,14 ( Suppl 3 ) : 10-18.
  • 4孙艳萍.冷沉淀的制备方法及临床输注[J].中国健康月刊,2011,30(7):309-310.
  • 5Mori F, Nardini I, Rossi P, et al. Progress in large-scale purifi- cation of factor Ⅷ/von Willebrand factor concentrates using ion- exchange chromatography[ J]. Vox Sang,2008,95 (4) :298-307.
  • 6郑炎,贾玉华,杨晓敏,等.二次病毒灭活冻干人凝血因子Ⅷ的研制[G]//中华医学会第八次全国血液学学术会议论文汇编.2004.
  • 7Burnouf T, Burnouf-Radosevich M, Huart JJ,et al. A highly pu- rified factor Ⅷ: c concentrate prepared from cryoprecipitate by ion-exchange chromatography[J]. Vox Sang,1991,60( 1 ) :8-15.
  • 8Cheng E, Jinzenji D, Paula A, et al. Purification of coagulation factor Ⅷ using chromatographic methods. Direct chromatogra- phy of plasma in anion exchange resins [ J ]. Biotechnol Lett, 2010, 32(9) :1207-1214.
  • 9D'Amici GM1 , Blasi B, D'Alessandro A,et al. Plasma-derived clotting factor Ⅷ:Heterogeneity evaluation in the quest for po- tential inhibitory-antibody stimulating factors [ J ]. Electrophore- sis ,2011, 32 ( 21 ) :2941-2950.
  • 10Morfini M, Coppola A, Franchini M, et al. Clinical use of factor Ⅷ and factor Ⅸ concentrates [ J ] Blood Transfus, 2013, 11 ( Suppl 4 ) : s55-63.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部